Yash Shah

Yash Shah, Ph.D., currently serves as Scientist II in R&D Immunology at Asklepios BioPharmaceutical, Inc. since October 2022, where responsibilities include designing and qualifying anti-AAV antibody assays and leading cross-functional teams to immunomodulate AAV immunogenicity. Previously, Yash was a Scientist II at BioAgilytix from February 2020 to July 2022, focusing on biomarker and immunogenicity assay development and validation, alongside leading GxP regulated studies. Earlier experience includes a Scientist I role at BioAgilytix and a Graduate Research Assistantship at the University of Florida from August 2015 to December 2019, concentrating on a novel diagnostic platform for osteoarthritis using magnetic nanoparticles. Yash began a research career as a Research and Development Intern at Nanotherapeutics, Inc. and holds a Ph.D. in Materials Science and Engineering and a Bachelor’s Degree in Biochemistry, both from the University of Florida.